Director
CurrentChange-agent overhauling Pfizer’s first foray into modern, 21st century media buying. Successfully deployed Pfizer’s transition into hyper-targeted media, expanded into new platforms within social, point-of-care, and TV-buying, and established a new format for media reporting leading to improved efficiencies.Partnering with Pfizer, Bristol-Myers Squibb, and Sumitomo Pharmaceuticals to deliver on business objectives. This includes the launch of Pfizer+Sumitomo’s first campaign addressed to women suffering with endometriosis. This also includes revamping Pfizer+Bristol-Myers Squibb’s use of TV advertising to enhance performance and insights against their target audience by leveraging the companies’ first instance of data-driven linear TV.Oversaw the launch and execution of more than $100MM in media spend during agency transition. Integral part of the successful transition and launch of Pfizer’s nearly $500M annual media budget in the handoff to Publicis. Leading a team of ten people, I established key processes and swim lanes for both the Pfizer and Publicis teams while standing up a media buying and management operation that ensured all teams were kept abreast of the latest status of launch.Leading a team of paid media strategists and planners supporting Pfizer's Women's Health and AFIB portfolios. Consistently bringing strategic and data-driven insights to overhaul the team's approach to advertising and marketing from the ground up. Counseled team members at all levels of experience while aligning towards a common goal and approach to deliver for Pfizer. Driving strategic optimizations for Pfizer's media activities which lead to $10M+ in savings in the first 60 days. This included leading the Pfizer team into their first foray into audience-first targeting and optimizations, which led to a 72% reduction in media waste. Further optimizations led to a 35% improvement in campaign ROI thanks to enhanced targeting across the campaign's channels.